WeightWatchers files for bankruptcy amid rise of weight-loss drugs
Briefly

WW International, formerly known as WeightWatchers, has filed for Chapter 11 bankruptcy to manage $1.15 billion in debt amid increasing competition from weight-loss drugs like Ozempic. CEO Tara Comonte emphasized the company's commitment to science-backed, holistic solutions focused on long-term health. The company plans to use the bankruptcy process to innovate and reinvest in its members, expecting to emerge as publicly traded in about 40 days without affecting current members.
As the conversation around weight shifts toward long-term health, our commitment to delivering the most trusted, science-backed, and holistic solutions has never been stronger, or more important.
The decisive actions we're taking today, with the overwhelming support of our lenders and noteholders, will give us the flexibility to accelerate innovation, reinvest in our members, and lead with authority in a rapidly evolving weight management landscape.
Read at www.aljazeera.com
[
|
]